How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of maximal effort cytoreductive surgery for advanced ovarian cancer

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Sundar S, Cummins C, Kumar S et al. (2022) Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study. BJOG: An International Journal of Obstetrics and Gynaecology 129: 1122–32

    2. Soo Hoo S, Marriott N, Houlton A et al. (2015) Patient-reported outcomes after extensive (ultraradical) surgery for ovarian cancer: results from a prospective longitudinal feasibility study. International Journal of Gynecological Cancer 25: 1599–607

    3. Cummins C, Kumar S, Long J et al. (2022) Investigating the impact of ultra-radical surgery on survival in advanced ovarian cancer using population-based data in a multicentre UK study. Cancers 14: 4362. https://doi.org/10.3390/cancers14184362

    4. Dahm-Kähler P, Holmberg E, Holtenman M et al. (2021) Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study. Gynecologic Oncology 161: 244–50

    5. Falconer H, Joneborg U, Krawiec K et al. (2020) Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population. Gynecologic Oncology 159: 58–65

    6. Horowitz NS, Miller A, Rungruang B et al. (2015) Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. Journal of Clinical Oncology 33: 937–43

    7. Tseng JH, Cowan RA, Zhou Q et al. (2018) Continuous improvement in primary debulking surgery for advanced ovarian cancer: do increased complete gross resection rates independently lead to increased progression-free and overall survival? Gynecological Oncology 151: 24–31

    8. Angeles MA, Hernandez A, Perez-Benavente A et al. (2022) The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer. Gynecologic Oncology 166: 8–17

    9. Phillips A, Sundar S, Singh K et al. (2019) The NICE classification for 'Ultra-radical (extensive) surgery for advanced ovarian cancer' guidance does not meaningfully predict postoperative complications: a cohort study. BJOG: An International Journal of Obstetrics and Gynaecology 126: 96–104

    10. Palmqvist C, Michaelsson H, Staf C et al. (2022) Complications after advanced ovarian cancer surgery-A population-based cohort study. Acta Obstetricia et Gynecologica Scandinavica 101:747–57

    11. Di Donato V, Kontopantelis E, Aletti G et al. (2017) Trends in mortality after primary cytoreductive surgery for ovarian cancer: a systematic review and metaregression of randomized clinical trials and observational studies. Annals of Surgical Oncology 24: 1688–97

    12. Hiu S, Bryant A, Gajjar K et al. (2022) Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer. Cochrane Database of Systematic Reviews Issue 8. Art. No.: CD007697. DOI: 10.1002/14651858.CD007697.pub3

    13. Ehmann S, Aviki EM, Sonoda Y et al. (2021) Diaphragm hernia after debulking surgery in patients with ovarian cancer. Gynecologic Oncology Reports 36: 100759

    14. Maxwell-Armstrong C, Dobbs S, Tierney G et al. (2022) Governance models to support patient safety when undergoing maximal effort cytoreductive surgery for advanced ovarian/fallopian tube/primary peritoneal cancer – a joint statement of ACPGBI, ASGBI, AUGIS and BGCS. Colorectal Disease 24: 6–7

    15. Querleu D, Planchamp F, Chiva L et al. (2017) European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery. International Journal of Gynecological Cancer 27: 1534–42